BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

992 related articles for article (PubMed ID: 21397634)

  • 1. Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain.
    Réus GZ; Stringari RB; Ribeiro KF; Ferraro AK; Vitto MF; Cesconetto P; Souza CT; Quevedo J
    Behav Brain Res; 2011 Aug; 221(1):166-71. PubMed ID: 21397634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic administration of ketamine elicits antidepressant-like effects in rats without affecting hippocampal brain-derived neurotrophic factor protein levels.
    Garcia LS; Comim CM; Valvassori SS; Réus GZ; Andreazza AC; Stertz L; Fries GR; Gavioli EC; Kapczinski F; Quevedo J
    Basic Clin Pharmacol Toxicol; 2008 Dec; 103(6):502-6. PubMed ID: 19067677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus.
    Garcia LS; Comim CM; Valvassori SS; Réus GZ; Barbosa LM; Andreazza AC; Stertz L; Fries GR; Gavioli EC; Kapczinski F; Quevedo J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):140-4. PubMed ID: 17884272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propofol pretreatment increases antidepressant-like effects induced by acute administration of ketamine in rats receiving forced swimming test.
    Wang X; Yang Y; Zhou X; Wu J; Li J; Jiang X; Qu Q; Ou C; Liu L; Zhou S
    Psychiatry Res; 2011 Jan; 185(1-2):248-53. PubMed ID: 20580983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf⁺/⁻ heterozygous null mice.
    Lindholm JS; Autio H; Vesa L; Antila H; Lindemann L; Hoener MC; Skolnick P; Rantamäki T; Castrén E
    Neuropharmacology; 2012 Jan; 62(1):391-7. PubMed ID: 21867718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus.
    Fortunato JJ; Réus GZ; Kirsch TR; Stringari RB; Stertz L; Kapczinski F; Pinto JP; Hallak JE; Zuardi AW; Crippa JA; Quevedo J
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1425-30. PubMed ID: 19632287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats.
    Itoh T; Tokumura M; Abe K
    Eur J Pharmacol; 2004 Sep; 498(1-3):135-42. PubMed ID: 15363987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurochemical and behavioural effects of acute and chronic memantine administration in rats: Further support for NMDA as a new pharmacological target for the treatment of depression?
    Réus GZ; Stringari RB; Kirsch TR; Fries GR; Kapczinski F; Roesler R; Quevedo J
    Brain Res Bull; 2010 Apr; 81(6):585-9. PubMed ID: 19954760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tianeptine treatment induces antidepressive-like effects and alters BDNF and energy metabolism in the brain of rats.
    Della FP; Abelaira HM; Réus GZ; Ribeiro KF; Antunes AR; Scaini G; Jeremias IC; dos Santos LM; Jeremias GC; Streck EL; Quevedo J
    Behav Brain Res; 2012 Aug; 233(2):526-35. PubMed ID: 22659397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of co-administration of memantine and sertraline on the antidepressant-like activity and brain-derived neurotrophic factor (BDNF) levels in the rat brain.
    Amidfar M; Réus GZ; Quevedo J; Kim YK; Arbabi M
    Brain Res Bull; 2017 Jan; 128():29-33. PubMed ID: 27825855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of glutathione, ERK1/2 phosphorylation and BDNF expression in the antidepressant-like effect of zinc in rats.
    Franco JL; Posser T; Brocardo PS; Trevisan R; Uliano-Silva M; Gabilan NH; Santos AR; Leal RB; Rodrigues AL; Farina M; Dafre AL
    Behav Brain Res; 2008 Apr; 188(2):316-23. PubMed ID: 18191237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acetylcysteine possesses antidepressant-like activity through reduction of oxidative stress: behavioral and biochemical analyses in rats.
    Smaga I; Pomierny B; Krzyżanowska W; Pomierny-Chamioło L; Miszkiel J; Niedzielska E; Ogórka A; Filip M
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):280-7. PubMed ID: 22820675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. St John's wort, hypericin, and imipramine: a comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and long-term administration in normal and stressed rats.
    Butterweck V; Winterhoff H; Herkenham M
    Mol Psychiatry; 2001 Sep; 6(5):547-64. PubMed ID: 11526469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of combined treatment with imipramine and metyrapone in the forced swimming test in rats. Behavioral and pharmacokinetic studies.
    Rogóz Z; Skuza G; Wójcikowski J; Daniel WA
    Pol J Pharmacol; 2003; 55(6):993-9. PubMed ID: 14730094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effect of imipramine and amantadine in the forced swimming test in rats. Behavioral and pharmacokinetic studies.
    Rogóz Z; Skuza G; Kuśmider M; Wójcikowski J; Kot M; Daniel WA
    Pol J Pharmacol; 2004; 56(2):179-85. PubMed ID: 15156068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression.
    Wesołowska A; Nikiforuk A
    Neuropharmacology; 2007 Apr; 52(5):1274-83. PubMed ID: 17320917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The beta3 adrenoceptor agonist, amibegron (SR58611A) counteracts stress-induced behavioral and neurochemical changes.
    Tamburella A; Micale V; Leggio GM; Drago F
    Eur Neuropsychopharmacol; 2010 Oct; 20(10):704-13. PubMed ID: 20537869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral proinflammatory markers associated with ketamine response in a preclinical model of antidepressant-resistance.
    Walker AJ; Foley BM; Sutor SL; McGillivray JA; Frye MA; Tye SJ
    Behav Brain Res; 2015 Oct; 293():198-202. PubMed ID: 26209292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of antidepressant-like effects but not brain-derived neurotrophic factor mRNA expression by the novel N-methyl-D-aspartate receptor antagonist neramexane in mice.
    Kos T; Legutko B; Danysz W; Samoriski G; Popik P
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1128-36. PubMed ID: 16740621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment.
    Larsen MH; Mikkelsen JD; Hay-Schmidt A; Sandi C
    J Psychiatr Res; 2010 Oct; 44(13):808-16. PubMed ID: 20172535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.